Navigation Links
DuPont, Dow AgroSciences Agree to Cross License Next-Generation Soybean Herbicide Tolerant Traits
Date:11/12/2009

New Traits Enable Farmers to Use More Effective Weed Control Solutions

Wilmington, DE and Indianapolis, IN (Vocus) November 12, 2009 -- DuPont and Dow AgroSciences, a wholly owned subsidiary of The Dow Chemical Company (NYSE: Dow), announced they have entered into a commercial cross-licensing agreement that will enable the two companies to deliver expanded herbicide-tolerant soybean options to farmers in the next decade.

Under the agreement, Dow AgroSciences is licensing non-exclusively its proprietary herbicide tolerant trait technology for soybeans to DuPont business Pioneer Hi-Bred. In addition, Pioneer is licensing non-exclusively its proprietary Optimum® GAT® trait for soybeans to Dow AgroSciences. Both companies have given the other rights to stack additional traits with their respective technology. Financial details of the agreement were not disclosed.

“This agreement gives us a new weed control option to help our customers meet their individual needs,” said Paul E. Schickler, president -- Pioneer. “Being able to offer farmers specific solutions to weed control is a key part of our Right Product, Right AcreSM strategy.”

Dow AgroSciences expects to submit herbicide-tolerant trait technology data to U.S. regulatory agencies this year. Dow AgroSciences anticipates commercialization early in the next decade pending regulatory authorizations.

“We are excited about the results of our investment in this next generation of technology in soybeans,” said Antonio Galindez, president and CEO -- Dow AgroSciences. “Our new herbicide-tolerant trait technology, in association with other leading weed control systems, offers growers the additional choices, unsurpassed flexibility, convenience and value that contribute to enhanced performance.”   

The new herbicide-tolerant trait technology allows growers to continue farming the way they want, but with improved weed control capabilities and performance. The system is designed to provide excellent control of glyphosate-resistant and other hard-to-control broadleaf weeds like morning glory, pigweeds including palmer amaranth, lambsquarters, marestail, waterhemp, giant and common ragweed, and velvetleaf. In anticipation of regulatory approvals for its herbicide-tolerant trait technology, Dow AgroSciences is developing new and improved herbicide solutions based on the proven, trusted 2,4-dichlorophenoxy acetic acid technology growers have used successfully for more than 60 years.

When stacked together, the Optimum® GAT® trait from Pioneer and the new herbicide-tolerant trait technology being developed by Dow AgroSciences would produce soybeans that are tolerant to 2,4-D, glyphosate and ALS herbicides. The Optimum® GAT® trait from Pioneer provides tolerance to glyphosate and the ALS class of herbicides. Optimum® GAT® soybeans have received U.S. regulatory approvals and a 2011 introduction is anticipated upon regulatory approvals in key importing countries. DuPont also anticipates the introduction of five new ALS-based herbicide products for Optimum® GAT® soybeans, including DuPont™ Freestyle™, Trigate™, Traverse™, Instigate™, and Diligent™ herbicides, upon U.S. and state approvals.

Dow AgroSciences LLC, based in Indianapolis, Indiana, USA, is a top-tier agricultural company that combines the power of science and technology with the "Human Element” to constantly improve what is essential to human progress. Dow AgroSciences provides innovative technologies for crop protection, pest and vegetation management, seeds, traits, and agricultural biotechnology to serve the world's growing population. Dow AgroSciences will market this technology in its soybean seed brands including Mycogen, Brodbeck, Dairyland, and Renze. Global sales for Dow AgroSciences, a wholly owned subsidiary of The Dow Chemical Company, are $4.5 billion. Learn more at www.dowagro.com.

Pioneer Hi-Bred, a DuPont business, is the world’s leading source of customized solutions for farmers, livestock producers and grain and oilseed processors. With headquarters in Des Moines, Iowa, Pioneer provides access to advanced plant genetics in nearly 70 countries.

DuPont is a science-based products and services company. Founded in 1802, DuPont puts science to work by creating sustainable solutions essential to a better, safer, healthier life for people everywhere. Operating in more than 70 countries, DuPont offers a wide range of innovative products and services for markets including agriculture and food; building and construction; communications; and transportation.

Forward-Looking Statements: This news release contains forward-looking statements based on management’s current expectations, estimates and projections. The company does not undertake to update any forward-looking statements as a result of future developments or new information. All statements that address expectations or projections about the future, including statements about the company’s strategy for growth, product development, market position, expected expenditures and financial results are forward-looking statements. Some of the forward-looking statements may be identified by words like “expects,” “anticipates,” “plans,” “intends,” “projects,” “indicates,” and similar expressions. These statements are not guarantees of future performance and involve a number of risks, uncertainties and assumptions. Many factors, including those discussed more fully elsewhere in this release and in DuPont’s filings with the Securities and Exchange Commission, particularly its latest annual report on Form 10-K, as well as others, could cause results to differ materially from those stated. These factors include, but are not limited to changes in the laws, regulations, policies and economic conditions of countries in which the company does business; competitive pressures; successful integration of structural changes, including acquisitions, divestitures and alliances; research and development of new products, including regulatory approval and market acceptance, and seasonality of sales of agricultural products.

DuPont
Doyle Karr
515-270-3428

Dow AgroSciences
Robyn Heine
317-337-4807

# # #

Read the full story at http://www.prweb.com/releases/DuPont_Dow/Pioneer_Hi-Bred/prweb3197354.htm.


'/>"/>
Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved  

Related biology technology :

1. DuPont, Genencor International and Tate & Lyle Honored for Groundbreaking Work in Developing Bio-PDO(TM)
2. Dow AgroSciences and Exelixis Plant Sciences Announce Major Research Collaboration, Asset Purchase to Advance Gene Discovery and Validation
3. Dow AgroSciences Success Presented to Wall Street
4. Dow AgroSciences, Sangamo BioSciences Announce the Achievement of Key Milestone in Plant Agriculture Collaboration
5. Dow AgroSciences, Martek Biosciences Form Alliance to Bring Omega-3 Fatty Acids to Food Industry
6. Dow AgroSciences, Sangamo BioSciences Announce the Achievement of Key Milestones in Plant Agriculture Collaboration
7. Dow AgroSciences Announces Early Exercise of Option for Commercial License With Sangamo BioSciences for Plants
8. Dow AgroSciences Receives Approval for Cultivation of HERCULEX(R) I Corn in Brazil
9. Dow AgroSciences Delivering Beyond Expectations
10. Dow AgroSciences, China National Rice Research Institute Announce Collaboration on Rice Research
11. Dow AgroSciences Receives Approval for New Technology to Control Cotton Pests in Brazil
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
DuPont, Dow AgroSciences Agree to Cross License Next-Generation Soybean Herbicide Tolerant Traits
(Date:2/23/2017)...  Capricor Therapeutics, Inc. (NASDAQ: CAPR), a biotechnology company developing ... that Linda Marbán, Ph.D, president and chief executive officer, is ... Cowen and Company 37th Annual Health Care Conference ... Boston, MA 29th Annual ROTH ... pm ET) Dana Point, CA ...
(Date:2/23/2017)... DIEGO and SAN FRANCISCO ... a privately-held regenerative medicine company, and Beyond Type 1, ... with type 1 diabetes, today announced a grant from ... a functional cure for type 1 and other insulin-requiring ... ViaCyte has been developing innovative stem cell-derived cell replacement ...
(Date:2/22/2017)...  Aratana Therapeutics, Inc. (NASDAQ: PETX), a pet therapeutics company ... products for companion animals, will host a live conference call ... discuss financial results from the fourth quarter and full year ... investors may access the audio webcast or use ... ...
(Date:2/22/2017)... ... February 22, 2017 , ... Park Systems , a leader in Atomic ... all SPIE attendees and Park customers on Feb. 27, 2017 from 12-2pm ... Jose Convention Center. The luncheon will feature a talk on Automated AFM for ...
Breaking Biology Technology:
(Date:2/7/2017)... , Feb. 7, 2017   MedNet Solutions ... the entire spectrum of clinical research, is pleased to ... , its innovative, highly flexible and award winning ... customers. iMedNet is a proven Software-as-a-Service ... Electronic Data Capture (EDC), but also delivers an entire ...
(Date:2/6/2017)... , Feb. 6, 2017 According to ... are driving border authorities to continue to embrace ... there are 2143 Automated Border Control (ABC) eGates ... deployed at more than 163 ports of entry ... to 2016 achieving a combined CAGR of 37%. ...
(Date:2/2/2017)... 2017   TapImmune, Inc. (NASDAQ: ... in the development of innovative peptide and gene-based ... and metastatic disease, announced today it has successfully ... a second clinical lot of TPIV 200, the ... The manufactured vaccine product will be used to ...
Breaking Biology News(10 mins):